Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.54 -0.09 (-2.48%)
As of: Sep 29, 2026 · 1:57 PM EDT

Galmed Pharmaceuticals (EOCN) EBIT Margin (2016 - 2018)

Updated

Galmed Pharmaceuticals (EOCN) recorded EBIT Margin of 525.76% in FY2018, down 613.78 percentage points from 1139.54% in FY2017.

Analysis

Galmed Pharmaceuticals (EOCN) EBIT Margin (2016 - 2018) Analysis & Trends

  • Per Business Quant data, EOCN's EBIT Margin was 1139.54% in FY2017 (-2475.45 pp) and 3614.99% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Galmed Pharmaceuticals 422,361.40 422,361.40 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 78.67%
Jun 30, 2018 961.11%
Mar 31, 2018 954.85%
Dec 31, 2017 1,329.93%
Sep 30, 2017 1,009.16%
Jun 30, 2017 993.70%
Mar 31, 2017 1,217.91%
Dec 31, 2016 1,734.67%
Sep 30, 2016 1,971.50%
API Access

Galmed Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOCN&period=max&api_key=YOUR_API_KEY